BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3791655)

  • 1. Interaction of IgG heavy-chain allotypes (Gm) and HLA in conferring susceptibility to thyroid carcinoma.
    Juhasz F; Balazs G; Kozma L; Kraszits E; Stenszky V; Farid NR
    Clin Endocrinol (Oxf); 1986 Jul; 25(1):17-21. PubMed ID: 3791655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation of susceptibility to and biologic behavior of thyroid epithelial cell cancer to HLA-DR1.
    Juhasz F; Balázs G; Stenszky V; Kozma L; Farid NR
    Cancer; 1986 Jul; 58(1):52-4. PubMed ID: 3486708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interaction between HLA and Gm for susceptibility to insulin-dependent diabetes].
    Dizier MH; Deschamps I; Hors J; Blanc M; Rivat-Peran L; Feingold N; Clerget-Darpoux F
    Rev Epidemiol Sante Publique; 1985; 33(4-5):337-40. PubMed ID: 3867988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of IgG heavy-chain allotypes (Gm) with Graves' disease in Hungary.
    Kozma L; Stenszky V; Kraszits E; Balazs C; Farid NR
    Exp Clin Immunogenet; 1985; 2(3):154-7. PubMed ID: 3939975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gm and Km allotypes in rheumatoid arthritis.
    Sanders PA; de Lange GG; Dyer PA; Grennan DM
    Ann Rheum Dis; 1985 Aug; 44(8):529-32. PubMed ID: 3927859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG heavy chain allotype (Gm), a genetic marker for human chromosome 14q32, and haematopoietic malignancies.
    Nakao Y; Matsumoto H; Tsuji K; Miyazaki T; Masaoka T; Nakayama S; Kinoshita K; Shingami T; Matsui T; Fujita T
    Clin Exp Immunol; 1984 Jun; 56(3):628-36. PubMed ID: 6430611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin allotype markers and HLA DR genes in type I diabetes mellitus.
    Schernthaner G; Mayr WR
    Metabolism; 1984 Sep; 33(9):833-6. PubMed ID: 6433149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG heavy-chain (Gm) allotypes and HLA-antigens in insulin-dependent diabetes mellitus in Korea.
    Okimoto K; Nakao Y; Matsumoto H; Min HK; Kim EJ; Lee TH; Yoon JS; Higa S; Oura T; Mimura G
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():283-7. PubMed ID: 6440310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary hepatocellular carcinoma and IgG heavy chain allotypes.
    Nakao Y; Matsumoto H; Okubo A; Miyazaki T; Iwasaki Y; Okimoto K; Yoshiba A; Kumada H; Fujita T
    Clin Exp Immunol; 1983 Jun; 52(3):493-8. PubMed ID: 6307557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
    Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gm markers in celiac disease.
    Carbonara AO; DeMarchi M; van Loghem E; Ansaldi N
    Hum Immunol; 1983 Feb; 6(2):91-5. PubMed ID: 6601100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gm allotypes in blacks with systemic lupus erythematosus.
    Fedrick JA; Pandey JP; Chen Z; Fudenberg HH; Ainsworth SK; Dobson RL
    Hum Immunol; 1983 Oct; 8(2):177-81. PubMed ID: 6643143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenetic and immunologic studies of differentiated thyroid cancer.
    Juhasz F; Boros P; Szegedi G; Balazs G; Suranyi P; Kraszits E; Stenszky V; Farid NR
    Cancer; 1989 Apr; 63(7):1318-26. PubMed ID: 2784072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactive effect of HLA and Gm tested in a study of 135 juvenile insulin-dependent diabetic families.
    Dizier MH; Deschamps I; Hors J; Blanc M; Rivat L; Clerget-Darpoux F
    Tissue Antigens; 1986 May; 27(5):269-78. PubMed ID: 3726862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
    Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
    J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible disorder of B-cell-related surveillance and malignant lymphoma of the thyroid.
    Matsubayashi S; Tamai H; Morita T; Matsuzuka F; Kuma K; Miyazaki T; Matsumoto H; Nagataki S; Volpé R
    Cancer; 1989 Dec; 64(11):2259-61. PubMed ID: 2804917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenetic study of thyroid hormone autoantibodies in a family.
    Nakamura S; Sugimoto M; Kosaka J; Komaki T; Kamura H; Miyazaki T; Matsumoto H; Sakata S
    J Endocrinol Invest; 1991 Feb; 14(2):131-4. PubMed ID: 2061568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population.
    de Jongh BM; van Romunde LK; Valkenburg HA; de Lange GG; van Rood JJ
    Ann Rheum Dis; 1984 Aug; 43(4):613-9. PubMed ID: 6433814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of immunoglobulin allotypes (Gm and Km), HLA, and sex in insulin-dependent (type 1) diabetes.
    Propert DN; Tait BD; Harrison LC
    Dis Markers; 1991; 9(1):43-5. PubMed ID: 1742944
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactive effect of genes associated with immunoglobulin allotypes and HLA specificities on susceptibility to Haemophilus influenzae disease.
    Granoff DM; Boies E; Squires J; Pandey JP; Suarez B; Oldfather J; Rodey GE
    J Immunogenet; 1984; 11(3-4):181-8. PubMed ID: 6520406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.